Crile, G. Jr. 123. Changing end results in patients with papillary carci- noma of the thyroid. 124. Surg. Gynecol. Obstet. 132: 460-8 (1971). Hazard, J.B., Crile, G. Jr., and Dempsey, W.S. osing tumors of the thyroid. Nonencapsulated scler- J. Clin. Endocrinol. 9: 1215 (1949). 130. Franssila, K.0. Prognosis in thyroid carcinoma. Cancer 36: 1138-46 (1975). Hazard, J.B. Small papillary carcinoma of the thyroid: A study with special reference to so-called nonencapsulated sclerosing tumor. Lab. Invest. 9: 86-97 (1960). Klinck, G.H. and Winship, T. Occult sclerosing carcinoma of the thyroid. Cancer 8: 701 (1955). Williams, E.D. The pathology of thyroid malignancy. Br. J. Surg. 62: 757-9 (1975). Sampson, R.J., Oka, H., Key, C.R., Buncher, C.R., and Iijima, S. Metastases from occult thyroid carcinoma: An autopsy study from Hiroshima and Nagasaki, Japan. Cancer 25: 803-11 (1970). Fukunaga, F.H. and Yatani, R. Geographic pathology of occult thyroid 131. Sawin, C.T. and Hershman, J.M. 125. 126. 127. 128. 129. carcinomas. Cancer 36: 1095-9 (1975). The TSH response to thyrotropin- releasing hormone (TRH) in young adult men: Intra-individual variation and relation to basal serum TSH and thyroid hormones. J. Clin. Endocrinol. Metab. 46: 217 (1978). Thein-Wai, W. and Larsen, P.R. Effects of weekly thyroxine administration on serum thyroxine and 3,5,3'-triiodothyronine, thyrotropin and thyrotropin response to thyrotropin-releasing hormone. J. Clin. 132. Endocrinol. Metab. 50: 660 (1980). 133. Tunbridge, W.M.G., Evered, D.C., Hall, R., Appleton, D., Brewis, M., Clark, F., Grimley Evans, J., Young, E., Bird, T., and Smith, P.A. The spectrum of thyroid disease in a community: The Wickham survey. Clin. Endocrinol. 7: 481 (1977). 134. Van Middlesworth, L. Factors influencing the thyroid uptake of iodine isotopes from nuclear fission: A review. Health Phys. 9: 1197-1211 (1963). 135. Evans, T.C., Kretzchmar, R.H., Hodges, R.E., and Song, C.W. 136. Hodges, R.E., Evans, T.C., Bradbury, J.T., and Keettel, W.C. uptake studies of the human fetal thyroid. (1967). mulation of radioactive iodine by human fetal thyroids. Endocrinol. Metab. 15: 661-7 (1955). 137. 138. Radioiodine J. Nucl. Med. 8: 157-60 The accu- J. Clin. Mays, C.W. (University of Utah), Personal communication, 1974. Russel, K.P., Rose, H., and Starr, P. The effects of radioactive iodine in maternal and fetal thyroid function during pregnancy. Surg. Gynecol. Obstet. 104: 560-4 (1957). Fisher, W.D., Voorhess, M.L., and Gardner, L.I. Congenital hypothyroidism in infant following maternal 131 therapy, with a review of hazards 139, of environmental radioisotope contamination. J. Pediat. 62: 132-46 rh) Ca cst 140. =~y (1963). Hamill, G.C., Jarman, J.A., and Wynne, M.D. Fetal effects of radioactive iodine therapy in a pregnant woman with thyroid cancer. Am. J. Obstet. Gynecol. 81: 1018-23 (1961). - 96 -